Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension.
about
Pathophysiology of portal hypertensionVascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.Is plasma urotensin II concentration an indicator of myocardial damage in patients with acute coronary syndrome?Urotensin II in cardiovascular regulation.Effects of a Long-Acting Formulation of Octreotide on Patients with Portal Hypertension.
P2860
Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Urotensin II: a novel vasoacti ...... sease and portal hypertension.
@en
type
label
Urotensin II: a novel vasoacti ...... sease and portal hypertension.
@en
prefLabel
Urotensin II: a novel vasoacti ...... sease and portal hypertension.
@en
P2093
P2860
P1433
P1476
Urotensin II: a novel vasoacti ...... sease and portal hypertension.
@en
P2093
John Colman
Mark Richards
Michael Bailey
Stuart Roberts
Tim Yandle
William Kemp
P2860
P304
P356
10.1111/J.1478-3231.2007.01539.X
P50
P577
2007-11-01T00:00:00Z